|Original language||English (US)|
|Number of pages||6|
|Journal||Journal of the American Academy of Child and Adolescent Psychiatry|
|State||Published - Mar 2007|
ASJC Scopus subject areas
- Developmental and Educational Psychology
- Psychiatry and Mental health
Access to Document
Other files and links
Is there a role for clozapine in the treatment of children and adolescents? / Findling, Robert L.; Frazier, Jean A.; Gerbino-Rosen, Ginny; Kranzler, Harvey N.; Kumra, Sanjiv; Kratochvil, Christopher J.In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 46, No. 3, 03.2007, p. 423-428.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Is there a role for clozapine in the treatment of children and adolescents?
AU - Findling, Robert L.
AU - Frazier, Jean A.
AU - Gerbino-Rosen, Ginny
AU - Kranzler, Harvey N.
AU - Kumra, Sanjiv
AU - Kratochvil, Christopher J.
N1 - Funding Information: Disclosure: None of the authors have conducted industry-funded studies of clozapine. Drs. Kumra, Kranzler, and Gerbino-Rosen have conducted studies of clozapine funded by the National Institute of Mental Health, but with study drug donated by Novartis. Dr. Kratochvil was previously a speaker for Novartis and has received grant support from, is a consultant to, and/or member of the speakers' bureaus of Eli Lilly, GlaxoSmithKline, Forest, Shire, Cephalon, Novartis, McNeil, Organon, AstraZeneca, and Pfizer. Dr. Findling has been a consultant to and conducted studies for Novartis, the manufacturer of Clozaril, and receives or has received research support from, acted as a consultant to, and/or served on the speakers' bureaus of Abbott, AstraZeneca, Bristol-Myers Squibb, Celltech-Medeva, Forest, GlaxoSmithKline, Johnson & Johnson, Lilly, New River, Novartis, Otsuka, Pfizer, Sanofi-Aventis, Shire, Solvay, and Wyeth. Dr. Frazier has received research support from, acted as a consultant to, and/or served on the speakers' bureaus of AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Forest Research Institute, Johnson & Johnson Pharmaceutical Research and Development, Otsuka Pharmaceutical Inc., and Pfizer. The other authors have no financial relationships to disclose. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2007/3
Y1 - 2007/3
UR - http://www.scopus.com/inward/record.url?scp=33847193467&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847193467&partnerID=8YFLogxK
U2 - 10.1097/chi.0b013e3180ed94e
DO - 10.1097/chi.0b013e3180ed94e
M3 - Article
C2 - 17314729
AN - SCOPUS:33847193467
VL - 46
SP - 423
EP - 428
JO - Journal of the American Academy of Child and Adolescent Psychiatry
JF - Journal of the American Academy of Child and Adolescent Psychiatry
SN - 0890-8567
IS - 3